ORIGINAL PAPER
CD127 expression in peripheral T cells of pediatric kidney transplant recipients
1
Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt
2
Department of Pediatrics, National Research Centre, Cairo, Egypt
3
Departments of Clinical Pathology, National Research Centre, Cairo, Egypt
4
Oncology Department, Faculty of Medicine, Cairo University, Cairo, Egypt
Submission date: 2021-06-16
Final revision date: 2021-07-18
Acceptance date: 2021-07-20
Publication date: 2021-09-29
Pediatr Pol 2021;96(3):173-180
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Regulatory T cells (Treg) are emerging as a potential therapy to facilitate long-term allograft survival what makes identification of reliable surface markers that are selectively expressed on Treg is crucial. The aim of this study is to evaluate the regulatory and suppressive functions of CD127 in peripheral T lymphocytes of pediatric kidney transplant recipients through studying the association their frequency and the development of rejection.
Material and methods:
Flow cytometric analysis of peripheral blood samples for the CD127 surface marker of 50 pediatric transplant recipients and 12 healthy controls was done. Clinical, laboratory, immunosuppressive therapy data and graft function of transplant recipients were collected and correlated with their CD127 peripheral blood expression.
Results:
CD127 expression in transplanted children was significantly elevated than that of controls (2.76 ±3.26% vs. 0.95 ±0.94%, p = 0.042). CD 127 expression did not correlate with donor relation, cytomegalovirus infection, acute rejection episodes or type of immunosuppressive drugs (p = 0.475, 0.479, 0.678 and 0.333 respectively). Patients with chronic allograft dysfunction (CAD) had significantly lowered frequencies of CD127 compared with those with stable graft function (0.61 ±0.549% vs. 3.08 ±3.375 %, p = 0.021).
Conclusions:
CD127+ cells is more expressed in transplanted children with stable graft function than those with CAD which makes the regulatory role of CD127+ cells post-transplantation a subject for further researches. The negative relationship between the frequency of CD127 and CAD supposes these cells as probable candidates for allowing allograft survival.
Regulatory T cells (Treg) are emerging as a potential therapy to facilitate long-term allograft survival what makes identification of reliable surface markers that are selectively expressed on Treg is crucial. The aim of this study is to evaluate the regulatory and suppressive functions of CD127 in peripheral T lymphocytes of pediatric kidney transplant recipients through studying the association their frequency and the development of rejection.
Material and methods:
Flow cytometric analysis of peripheral blood samples for the CD127 surface marker of 50 pediatric transplant recipients and 12 healthy controls was done. Clinical, laboratory, immunosuppressive therapy data and graft function of transplant recipients were collected and correlated with their CD127 peripheral blood expression.
Results:
CD127 expression in transplanted children was significantly elevated than that of controls (2.76 ±3.26% vs. 0.95 ±0.94%, p = 0.042). CD 127 expression did not correlate with donor relation, cytomegalovirus infection, acute rejection episodes or type of immunosuppressive drugs (p = 0.475, 0.479, 0.678 and 0.333 respectively). Patients with chronic allograft dysfunction (CAD) had significantly lowered frequencies of CD127 compared with those with stable graft function (0.61 ±0.549% vs. 3.08 ±3.375 %, p = 0.021).
Conclusions:
CD127+ cells is more expressed in transplanted children with stable graft function than those with CAD which makes the regulatory role of CD127+ cells post-transplantation a subject for further researches. The negative relationship between the frequency of CD127 and CAD supposes these cells as probable candidates for allowing allograft survival.
REFERENCES (33)
1.
Nankivell BJ, Alexander SI. Rejection of the kidney allograft. N Engl J Med 2010; 363: 1451-1462.
2.
Zheng Y, Rudensky YA. Foxp3 in control of the regulatory T cell lineage. Nature Immunology 2008; 8: 457-462.
3.
Kitamura N, Murata S, Ueki T, et al. Co-stimulation can abrogate Foxp3+ regulatory T cell mediated suppression of antitumor immunity. Int J Cancer 2009; 125: 630-638.
4.
Liu W, Putnam AL, Xu-yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 203: 1701-1711.
5.
Allan SE, Crome SQ, Crellin NK, et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007; 19: 345-354.
6.
Ciebiada M, Kasztalska K, Gorska-Ciebiada M, et al. Expression of IL-7 receptor in human peripheral regulatory T cells. Arch Med Sci 2013; 9: 555-560.
7.
Huang PC, Yang CY, Lee CY, et al. Pediatric renal transplantation: Results and prognostic factors Asian J Surg 2013; 36: 53-57.
8.
Fleiner F, Fritsche L, Glander P, et al. Reporting of rejection after renal transplantation in large immunosuppressive trials: biopsy-proven, clinical, presumed, or treated rejection? Transplantation 2006; 81: 655-659.
9.
Chapman JR, O’Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol 2005; 16: 3015-3026.
10.
Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753-760.
11.
Fadel FI, Elghoroury EA, Elshamaa MF, et al. Lymphocyte Activation Markers in Pediatric Kidney Transplant Recipients. Int J Biomed Sci 2015; 11: 121-130.
12.
Ekong UD, Luo X, Yu M, et al. Lymphocyte activation markers may predict the presence of donor specific alloreactivity in pediatric living related liver transplant recipients. Hum Immunol 2011; 72: 392-397.
13.
Lopez-Hoyos M, Segundo DS, Fernández-Fresnedo G, et al. Regulatory T cells in renal transplantation and modulation by immunosuppression. Transplantation 2009; 88: S31.
14.
Issa F Wood KJ. CD4+ regulatory T cells in solid organ transplantation. Curr Opin Organ Transplant 2010; 15: 757-764.
15.
Codarri L, Vallotton L, Ciuffreda D, et al., Expansion and tissue infiltration of an allospecific CD4+ CD25+ CD45RO+ IL-7Rαhigh cell population in solid organ transplant recipients. J Exp Med 2007; 204: 1533-1541.
16.
Vallotton L, Hadaya K, Venetz JP, et al. Monitoring of CD4+ CD25high IL-7Rαhigh activated T cells in kidney transplant recipients. Clin J Am Soc Nephrol 2011; 6: 2025-2033.
17.
Alonso-Arias R, Suárez-Alvarez B, López-Vázquez A, et al. CD127low expression in CD4+ CD25high T cells as immune biomarker of renal function in transplant patients. Transplantation 2009; 88: S85-S93.
18.
Pablo J E, van de Berg J, Hoevenaars EC, et al. Circulating lymphocyte subsets in different clinical situations after renal transplantation. Immunology 2012; 136: 198-207.
19.
Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203: 1693-1700.
20.
Warnecke G, Bushell A, Nadig SN, Wood KJ. Regulation of transplant arteriosclerosis by CD25+CD4+ T cells generated to alloantigen in vivo. Transplantation 2007; 83: 1459-1465.
21.
Klein S, Kretz CC, Krammer PH, Kuhn A. CD127 (low/-) and Fox P3 (1) expression levels characterize different regulatory T-cell populations in human peripheral blood. J Invest Dermatol 2010; 130: 492-499.
22.
Veronese F, Rotman S, Smith RN, et al. Pathological and clinical correlates of FOXP3+ cells in renal allografts during acute rejection. Am J Transplant 2007; 7: 914-922.
23.
Yapici U, Bemelman FJ, Scheepstra CG, et al. Intragraft FOXP3 protein or mRNA during acute renal allograft rejection correlates with inflammation, fibrosis, and poor renal outcome. Transplantation 2009; 87: 1377-1380.
24.
Fourtounas C, Dousdampanis P, Sakellaraki P, et al. Different immunosuppressive combinations on T-cell regulation in renal transplant recipients. Am J Nephrol 2010; 32: 1-9.
25.
Westall GP, Paraskeva MA, Snell GI. Antibody-mediated rejection. Curr Opin Organ Transplant 2015; 20: 492-497.
26.
Shi J, Luo F, Shi Q, et al. Increased circulating follicular helper T cells with decreased programmed death-1 in chronic renal allograft rejection. BMC Nephrol 2015; 16: 182.
27.
de Graav GN, Dieterich M, Hesselink DA, et al. Follicular T helper cells and humoral reactivity in kidney transplant patients. Clin Exp Immunol 2015; 180: 329-340.
28.
Hester J, Mills N, Shankar S, et al. Th17 cells in alemtuzumab-treated patients: the effect of long-term maintenance immunosuppressive therapy. Transplantation 2011; 91: 744-750.
29.
Tsaur I, Gasser M, Aviles B, et al. Donor antigen-specific regulatory T-cell function affects outcome in kidney transplant recipients. Kidney Int 2011; 79: 1005-1012.
30.
Miroux C, Morales O, Ghazal K, et al. In vitro effects of cyclosporine A and tacrolimus on regulatory T-cell proliferation and function. Transplantation 2012; 94: 123-131.
31.
Braitch M, Harikrishnan S, Robins RA, et al. Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis. Acta Neurol Scand 2009; 119: 239-245.
32.
Karagiannidis C, Akdis M, Holopainen P, et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004; 114: 1425-1433.
33.
Scottà C, Fanelli G, Hoong SJ, et al. Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells. Haematologica 2016; 101: 91-100.
Share
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
